Immunoregulatory nanomedicine for respiratory infections

Y Xiao, Y Huang, M Xie, M Yang, Y Tao, L Liu… - Nature Reviews …, 2024 - nature.com
Immune-regulation strategies, such as vaccination and immunotherapy, are key to the
prevention and treatment of respiratory infectious diseases. In particular, nanomedicines can …

Coccidioidomycosis and host microbiome interactions: What we know and what we can infer from other respiratory infections

S Tejeda-Garibay, KK Hoyer - Journal of Fungi, 2023 - mdpi.com
Between 70 and 80% of Valley fever patients receive one or more rounds of antibiotic
treatment prior to accurate diagnosis with coccidioidomycosis. Antibiotic treatment and …

[HTML][HTML] Effects of lung inflammation and injury on pulmonary tissue penetration of meropenem and vancomycin in a model of unilateral lung injury

J Geilen, M Kainz, B Zapletal, T Schweiger… - International Journal of …, 2024 - Elsevier
Objective Timing and dosing of antimicrobial therapy is key in the treatment of pneumonia in
critically ill patients. It is uncertain whether presence of lung inflammation and injury affects …

Rational use of antibacterials in pleural empyema

NG Bachinsky, A Caracaş, S Latus… - … în țările cu venituri mici și …, 2024 - ibn.idsi.md
Introduction. Pleural empyema remains a significant cause of morbidity and mortality
globally. The rising incidence of this complex pathology necessitates an evaluation of …